Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
4
CTVA Quote, Financials, Valuation and Earnings
Last price:
$57.45
Seasonality move
:
9.04%
Day range:
$56.15 - $57.66
52-week range:
$44.01 - $64.20
Dividend yield:
1.16%
P/E ratio:
57.49x
P/S ratio:
2.39x
P/B ratio:
1.58x
Volume:
2.1M
Avg. volume:
3.8M
1-year change:
19.93%
Market cap:
$39.1B
Revenue:
$17.2B
EPS (TTM):
$0.99
Analysts' Opinion
-
Consensus RatingCorteva has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $66.45, Corteva has an estimated upside of 16.75% from its current price of $56.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $57.00 representing 100% downside risk from its current price of $56.92.
Fair Value
-
According to the consensus of 18 analysts, Corteva has 16.75% upside to fair value with a price target of $66.45 per share.
CTVA vs. S&P 500
-
Over the past 5 trading days, Corteva has underperformed the S&P 500 by -5.09% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Corteva does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Corteva revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Corteva reported revenues of $2.3B.
Earnings Growth
-
Corteva has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Corteva reported earnings per share of -$0.76.
Enterprise value:
42.6B
EV / Invested capital:
1.39x
Price / LTM sales:
2.39x
EV / EBIT:
38.75x
EV / Revenue:
2.56x
PEG ratio (5yr expected):
53.19x
EV / Free cash flow:
65.41x
Price / Operating cash flow:
61.18x
Enterprise value / EBITDA:
18.23x
Gross Profit (TTM):
$7.2B
Return On Assets:
1.63%
Net Income Margin (TTM):
4.18%
Return On Equity:
2.76%
Return On Invested Capital:
2.32%
Operating Margin:
-19.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $17.1B | $17.3B | $16.6B | $2.6B | $2.3B | |
| Gross Profit | $7B | $7.3B | $7.2B | $944M | $761M | |
| Operating Income | $1.8B | $2B | $1.9B | -$265M | -$465M | |
| EBITDA | $3.2B | $2.6B | $2.3B | -$80M | -$261M | |
| Diluted EPS | $1.87 | $1.30 | $0.99 | -$0.45 | -$0.76 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $14.1B | $14.1B | $15B | $16.3B | $15.6B | |
| Total Assets | $41.7B | $41.1B | $40.7B | $43.1B | $41.9B | |
| Current Liabilities | $7.7B | $7.8B | $8.9B | $10.3B | $10.4B | |
| Total Liabilities | $17.3B | $16.1B | $15.6B | $17.6B | $16.9B | |
| Total Equity | $24.3B | $25B | $25.1B | $25.5B | $25B | |
| Total Debt | $3.2B | $2.5B | $2.9B | $5.9B | $5.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $409M | $1.3B | -$99M | -$244M | |
| Cash From Investing | -$600M | -$2B | -$680M | -$229M | -$161M | |
| Cash From Financing | -$962M | $1.8B | -$470M | $218M | $993M | |
| Free Cash Flow | $774M | -$148M | $651M | -$261M | -$398M | |
CTVA
Sector
Market Cap
$39.1B
$18.8M
Price % of 52-Week High
88.66%
57.39%
Dividend Yield
1.16%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
19.93%
-18.92%
Beta (5-Year)
0.771
1.064
Dividend yield:
1.16%
Annualized payout:
$0.62
Payout ratio:
63.17%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$57.91
200-day SMA
Buy
Level
$56.18
Bollinger Bands (100)
Sell
Level
54.51 - 60.53
Chaikin Money Flow
Buy
Level
149.2M
20-day SMA
Sell
Level
$60.00
Relative Strength Index (RSI14)
Sell
Level
38.84
ADX Line
Buy
Level
13.83
Williams %R
Buy
Level
-86.3335
50-day SMA
Sell
Level
$59.59
MACD (12, 26)
Sell
Level
-0.76
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
155.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.8024)
Buy
CA Score
(Annual)
Level (0.236)
Buy
Beneish M-Score
(Annual)
Level (-2.5857)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.5207)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Stock Forecast FAQ
In the current month, CTVA has received 12 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CTVA average analyst price target in the past 3 months is $66.45.
-
Where Will Corteva Stock Be In 1 Year?
According to analysts, the consensus estimate is that Corteva share price will rise to $66.45 per share over the next 12 months.
-
What Do Analysts Say About Corteva?
Analysts are divided on their view about Corteva share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Corteva is a Sell and believe this share price will drop from its current level to $57.00.
-
What Is Corteva's Price Target?
The price target for Corteva over the next 1-year time period is forecast to be $66.45 according to 18 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is CTVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Corteva is a Buy. 12 of 18 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CTVA?
You can purchase shares of Corteva via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Corteva shares.
-
What Is The Corteva Share Price Today?
Corteva was last trading at $57.45 per share. This represents the most recent stock quote for Corteva. Yesterday, Corteva closed at $56.92 per share.
-
How To Buy Corteva Stock Online?
In order to purchase Corteva stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.07% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
